Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89.

Loading...
Thumbnail Image

Embargo End Date

Authors

Allott, L
Da Pieve, C
Meyers, J
Spinks, T
Ciobota, DM
Kramer-Marek, G
Smith, G

Document Type

Journal Article

Date

2017-07-27

Date Accepted

2017-07-07

Abstract

The future of 89Zr-based immuno-PET is reliant upon the development of new chelators with improved stability compared to the currently used deferoxamine (DFO). Herein, we report the evaluation of the octadentate molecule DFO-HOPO (3) as a suitable chelator for 89Zr and a more stable alternative to DFO. The molecule showed good potential for the future development of a DFO-HOPO-based bifunctional chelator (BFC) for the radiolabelling of biomolecules with 89Zr. This work broadens the selection of available chelators for 89Zr in search of improved successors to DFO for clinical 89Zr-immuno-PET.

Citation

Chemical communications (Cambridge, England), 2017, 53 (61), pp. 8529 - 8532

Source Title

Publisher

ROYAL SOC CHEMISTRY

ISSN

1359-7345

eISSN

1364-548X

Research Team

Medicinal Chemistry 1
PET Radiochemistry
Preclinical Molecular Imaging

Notes